SEP 7, 2026 · JOURNAL ARTICLE
Preclinical models for cancer immunotherapy: a systematic review of ex vivo and in vitro platforms
Cancer Immunology Immunotherapy
This is a systematic review of preclinical models (in vitro and ex vivo platforms) without primary efficacy data, clinical outcomes, or comparative effectiveness evidence; it maps landscape and provides catalogue value but does not establish whether any model predicts clinical benefit.
Reported
Number of included studies75
Number of cancer types covered23
Main model types identified6